The present invention provides a drug injection device (100) comprising a first element (140) and a second element (103) configured to undergo unidirectional movement relative to each other corresponding to an action performed on or by the drug injection device (100), wherein the first element (140) comprises a plurality of serially disposed protrusions (143), wherein the second element (103) comprises first and second deflectable transducers (103a/153a, 103b/153b) configured for sequentially cooperating with the plurality of protrusions (143), and wherein a processor (151) is electrically connected with the first and second deflectable transducers (103a/153a, 103b/153b) to register activation signals, wherein the protrusion configuration is so disposed on the first element (140) and the first and second deflectable transducers (103a/153a, 103b/153b) are so disposed on the second element (103) that a second activation signal generated by the second deflectable transducer (103b/153b) is delayed relative to a first activation signal generated by the first deflectable transducer (103a/153a) as the first element (140) and the second element (103) move relative to each other, and wherein the processor (151) is configured to provide a) a first control action if a time delay between the first and second activation signals is above or equal to a pre-defined value, and b) a second control action if said time delay is below said pre-defined value.

A needle-free injector monitors the compression of a gas bubble within a cartridge of injectate during operating of a plunger in a pre-injection phase. When the gas bubble becomes sufficiently compressed (e.g., at or near the equilibrium pressure during the piercing phase), the velocity of the plunger of the needle-free injector is changed to the piercing rate for delivery of the injectate to a target. By detecting the gas bubble compression prior to delivery of injectate in this manner, an injection stream can be controlled to more closely reproduce a target injection profile. For example, the integrator error for an injector control model can be mitigated, stream acceleration can be optimized/maximized, and overshoot in the injector response (e.g., stream velocity or plunger movement) can be minimized.

The present disclosure relates to a drug delivery device, including: a body adapted to retain a medicament cartridge, a cap attachable to a distal end of the body to cover an opening thereof, an activation mechanism arranged within the body,
wherein the cap includes an activation feature adapted to be inserted into an activation opening of the body in order to actuate the activation mechanism or allow actuation thereof.

The present disclosure relates to a stopper adapted for use in a drug delivery device. In one implementation, the stopper includes a rigid casing having a shape adapted to fit within a barrel of the drug delivery device; electronics disposed and sealed within the rigid casing; and an elastomeric seal disposed around at least a dispensing end of the rigid casing and a side of the rigid casing. The electronics include a power source and at least one of a transducer or a sensor coupled to the power source. The elastomeric seal comprises a single continuous material.

An apparatus for discharging a dose of a fluid substance to an animal, the apparatus including: a delivery assembly adapted to discharge the dose of the substance to the animal; and a control system operatively associated with the delivery assembly so as to selectively operate the delivery assembly, wherein the control system is adapted to measure the discharge of the fluid substance from the delivery assembly such that the dose is discharged when the delivery assembly is operated.

A drug delivery device is disclosed that includes a housing including a channel, a drug reservoir fitting into the channel, and a friction element extending from a housing to the channel to contact an exterior side wall of the reservoir when the reservoir is inserted into the channel. The friction element is configured and oriented to wedge between the exterior wall and the reservoir when the reservoir is rotated in a first rotational direction.

Embodiments including an injection device having a housing with an outer surface, an inner surface, a proximal end and a distal end, and a defining a chamber extending between the proximal end and the distal end are provided herein. The device may include a plunger having a first end and a second end, the plunger being movable proximally and distally within the chamber of the housing, the plunger comprising a plunger rod extending from the first end to the second end of the plunger; and a plunger limiting mechanism configured to interface with the plunger rod, to limit the proximal movement of the plunger and prevent removal of the plunger from the housing.

The present invention relates to a rectal delivery device in the form of a syringe with improved locking mechanism for the delivery of an appropriate dosage of a medicament, thereby minimizing errors. More particularly, the present invention provides syringes with improved lock control units for delivering diazepam formulations for the treatment of patients experiencing epileptic seizures.

A cannula hub includes a shaft mount segment and a cannula coupling segment. A set of coupling nubbins radially extend from the outer surface of the cannula coupling segment. The coupling nubbins are aligned with one another along a helical cannula coupling pathway on the outer surface and are adapted to be received within a cooperative helical groove on a transfer vessel. The coupling nubbins have a protrusion projection distance that is greater than the depth of the groove. When a sufficient rotational force is applied to the cannula hub, the coupling nubbins score the inside face of the groove which increases the groove depth and enables the coupling nubbins to advance along the groove while forming a tight compression fit of the coupling nubbins within the groove.

A delivery device for delivering a gel or liquid pharmaceutical to a treatment site, the delivery device including a body extending from a delivery tip, the body defining a cavity for retaining a pharmaceutical or a pre-assembled cartridge holding the pharmaceutical; and a driver for mechanically discharging the pharmaceutical from the cartridge to the delivery tip. The driver may be adapted to release a consistent flow of the pharmaceutical. In addition, the delivery device may be biased into a release configuration.